Skip to main content
Clinical Trials/NCT03198494
NCT03198494
Enrolling by Invitation
N/A

Low Frequency Acoustic Stimulation During Sleep for Seizure Suppression

NYU Langone Health1 site in 1 country36 target enrollmentAugust 17, 2017
ConditionsEpilepsy

Overview

Phase
N/A
Intervention
Not specified
Conditions
Epilepsy
Sponsor
NYU Langone Health
Enrollment
36
Locations
1
Primary Endpoint
Interictal Discharge frequency
Status
Enrolling by Invitation
Last Updated
last year

Overview

Brief Summary

The objective of this study is to test the feasibility and physiological effect of low-frequency (1 Hz) acoustic stimulation delivered during nocturnal NREM sleep in epilepsy patients. The long-term goal is to develop this protocol for daily, long-term use in a home setting, for nocturnal seizure and IED suppression

Detailed Description

1. To test the feasibility of wearing an earphone system delivering acoustic stimulation during a night of sleep in adult epilepsy patients monitored in an inpatient unit. 2. To determine the acute physiological effects of low-frequency acoustic stimulation on interictal epileptiform discharge (IED) frequency during NREM sleep in adult patients with epilepsy in an ambulatory setting. 3. To determine the feasibility of applying low-frequency acoustic stimulation in a long-term home setting in adult epilepsy patients with frequent nocturnal seizures.

Registry
clinicaltrials.gov
Start Date
August 17, 2017
End Date
November 21, 2028
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18-60 years old
  • Able to provide informed consent
  • Fluent in English
  • Frequent nocturnal IEDs (≥ 10% of the sleep record)
  • Monitored on the adult epilepsy monitoring unit (EMU, for Aim 1 only) Additional inclusion criteria for Aim 3
  • Frequent nocturnal seizures (≥1 per week)

Exclusion Criteria

  • Hearing impairment
  • Diagnosis of a sleep disorder (sleep apnea, periodic limb movements of sleep, or other medical conditions with frequent arousals)
  • Psychoactive medication use (other than AEDs, for example SSRIs, antipsychotics, BDZ, or stimulants)
  • Seizures ≤ 24 hours prior to study.
  • Alcohol or recreational drug use in the 24 hours prior to the study
  • MOCA \<26
  • History of recent travel across time zones within the 1 month prior to study activities
  • Shift work for 1 month prior to study activities Additional Exclusion Criteria for Aim 3
  • No medication changes at least 1 month before study, and during 3 months of study activities

Outcomes

Primary Outcomes

Interictal Discharge frequency

Time Frame: 72 hours

IED frequency during nighttime sleep as measured by a 72 hour ambulatory EEG

Successful System Training

Time Frame: 72 hours

Assessment of how well participants learn to use stimulation smart-phone application and headphones, defined as the percentage of subjects with correctly maintained earphones during the first four hours of nocturnal sleep in the first days of use.

System Adherence

Time Frame: 2 months

Percentage of nights during which patients were compliant with the acoustic stimulation device during two months of home use (1 month control acoustic condition, 1 month 1Hz stimulation) determined weekly by patient self-report

Secondary Outcomes

  • System Use effect on Features of Sleep(72 hours)
  • Seizure Control(3 months)

Study Sites (1)

Loading locations...

Similar Trials